Inhibition of Food Intake

Advances in Pharmacology

Volumn 52, Issue , 2005, Pages 79-98

  Young, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; ANTIDIABETIC AGENT;

ANIMAL; AREA POSTREMA; DRUG EFFECT; EATING; HUMAN; PHYSIOLOGY; PSYCHOPHYSIOLOGY; REVIEW; SUBFORNICAL ORGAN;

AMYLOID; ANIMALS; AREA POSTREMA; EATING; HUMANS; HYPOGLYCEMIC AGENTS; SATIETY RESPONSE; SUBFORNICAL ORGAN;

EID: 33645228363     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)52005-2     Document Type: Review

References (114)

1. Arnelo U., Blevins J.E., Larsson J., Permert J., Westermark P., Reidelberger R.D., and Adrian T.E. Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats. Scand. J. Gastroenterol. 31 (1996) 83-89
2. Arnelo U., Permert J., Adrian T.E., Larsson J., Westermark P., and Reidelberger R.D. Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am. J. Physiol. 40 (1996) R1654-R1659
3. Arnelo U., Permert J., Granqvist L., Adrian T., Westermark P., Smith D., and Reidelberger R. Effects of AC187, IAPP 8-37, and CGRP 8-37 on IAPP-induced anorexia in rats. Proc. Neurosci. Abstr. 23 (1997) 102.37
4. Arnelo U., Permert J., Larsson J., Reidelberger R.D., Arnelo C., and Adrian T.E. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: Studies using a novel aortic catheterization technique. Endocrinology 138 (1997) 4081-4085
5. Arnelo U., Reidelberger R., Adrian T.E., Larsson J., and Permert J. Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275 (1998) R1537-R1542
6. Arnelo U., Herrington M.K., Theodorsson E., Adrian T.E., Reidelberger R., Larsson J., Marcusson J., Strommer L., Ding X.Z., and Permert J. Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain. Brain Res. 887 (2000) 391-398
7. Asarian L., Eckel L.A., and Geary N. Behaviorally specific inhibition of sham feeding by amylin. Peptides 19 (1998) 1711-1718
8. Balasubramaniam A., Renugopalakrishnan V., Stein M., Fischer J.E., and Chance W.T. Syntheses, structures and anorectic effects of human and rat amylin. Peptides 12 (1991) 919-924
9. Balasubramaniam A., Zhang F.S., Thomas I., and Chance W.T. Amylin increases transport of tyrosine and tryptophan into brain. Soc. Neurosci. Abstr. 17 (1991) 976
10. Baldo B.A., and Kelley A.E. Effects of insulin or amylin infusion into the nucleus accumbens shell on unconditioned exploratory and ingestive behaviors. Soc. Neurosci. Abstr. 25 (1999) 2141
11. Barth S.W., Riediger T., Lutz T.A., and Rechkemmer G. Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat. Neurosci. Lett. 341 (2003) 131-134
12. Beaumont K., Kenney M.A., Young A.A., and Rink T.J. High affinity amylin binding sites in rat brain. Mol. Pharmacol. 44 (1993) 493-497
13. Benoit S.C., McQuade J.A., Clegg D.J., Xu M., Rushing P.A., Woods S.C., and Seeley R.J. Altered feeding responses in mice with targeted disruption of the dopamine-3 receptor gene. Behav. Neurosci. 117 (2003) 46-54
14. Berenbaum M.C. Criteria for analyzing interactions between biologically active agents. Adv. Cancer Res. 35 (1981) 269-335
15. Berenbaum M.C. The expected effect of a combination of agents: The general solution. J. Theor. Biol. 114 (1985) 413-431
16. Bhavsar S.P., Gedulin B.R., Beaumont K., Rink T.J., and Young A.A. Inhibition of gastric emptying and of food intake appear to be independently controlled in rodents. Soc. Neurosci. Abstr. 21 (1995) 460
17. Bhavsar S., Watkins J., and Rink T. Synergistic effect of amylin and cholecystokinine octapeptide on food intake in mice. Diabetes 45 (1996) 333A
18. Bhavsar S., Watkins J., and Young A. Comparison of central and peripheral administration of amylin on reduction of food intake in rats. Diabetologia 40 suppl 1 (1997) A302
19. Bhavsar S., Watkins J., and Young A. The effect of amylin on food intake appears to be centrally mediated in rats. Diabetes 40 (1997) 254A
20. Bhavsar S., Watkins J., and Young A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol. Behav. 64 (1998) 557-561
21. Birkemo L.S., Johnson M.F., and Ervin G.N. CCK-8 and amylin produce different patterns of effects on anorexia and delayed gastric emptying. Proc. Neurosci. Abstr. 21 (1995) 459
22. Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., and Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur. J. Pharmacol. 454 (2002) 189-192
23. Chance W.T., Balasubramaniam A., Zhang F.-S., and Fischer J.E. Hyperthermia following the intrahypothalamic administration of amylin. Surg. Forum 42 (1991) 84-86
24. Chance W.T., Balasubramaniam A., Zhang F.S., Wimalawansa S.J., and Fischer J.E. Anorexia following the intrahypothalamic administration of amylin. Brain Res. 539 (1991) 352-354
25. Chance W.T., Balasubramaniam A., Chen X., and Fischer J.E. Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin. Peptides 13 (1992) 961-964
26. Chance W.T., Balasubramaniam A., Thomas I., and Fischer J.E. Amylin increases transport of tyrosine and tryptophan into the brain. Brain Res. 593 (1992) 20-24
27. Chance W.T., Balasubramaniam A., Stallion A., and Fischer J.E. Anorexia following the systemic injection of amylin. Brain Res. 607 (1993) 185-188
28. Chapman I., Parker B., Doran S., Feinle-Bisset C., Wishart J., Wang Y., Gao H.-Y., McIntyre S., Burrell T., Deckhut D., Weyer C., and Horowitz M. Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over study. Diabetes 53 suppl. 2 (2004) A82
29. Chapman I., Parker B., Doran S., Feinle-Bisset C., Wishart J., Wang Y., Lush C., McIntyre S., Burrell T., Deckhut D., Weyer C., and Horowitz M. Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over study. Diabetologia 47 suppl. 1 (2004) A283-A284
30. Davidowa H., Ziska T., and Plagemann A. Arcuate neurons of overweight rats differ in their responses to amylin from controls. Neuroreport 15 (2004) 2801-2805
31. Del Prete E., Schade B., Riediger T., Lutz T.A., and Scharrer E. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats. Physiol. Behav. 75 (2002) 593-599
32. Devine E., and Young A.A. Weight gain in male and female mice with amylin gene knockout. Diabetes 47 suppl. 1 (1998) A317
33. Edwards B.J.A., and Morley J.E. Amylin. Life Sci. 51 (1992) 1899-1912
34. Edwards G.L., Power J.D., and Young A.A. Attenuation of the satiogenic effects of amylin by lesions of the area postrema, but not by intraperitoneal capsaicin. Proc. Neurosci. Abstr. 24 (1998) 406.3
35. Emond M., Schwartz G.J., and Moran T.H. Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1315-R1321
36. Feinle C., O'Donovan D., and Horowitz M. Carbohydrate and satiety. Nutr. Rev. 60 (2002) 155-169
37. Fineman M., Maggs D., Burrell T., Velte M., and Kolterman O. Addition of pramlintide to insulin therapy in type 1 diabetes: Impact on glycemic and weight control stratified by BMI. Diabetes 50 suppl. 2 (2001) A112
38. Flood J.F., and Morley J.E. Differential effects of amylin on memory processing using peripheral and central routes of administration. Peptides 13 (1992) 577-580
39. Fraser K.A., Raizada E., and Davison J.S. Oral-pharyngeal-esophageal and gastric cues contribute to meal-induced c-fos expression. Am. J. Physiol. 268 (1995) R223-R230
40. Freed W.J., Perlow M.J., and Wyatt R.J. Calcitonin: Inhibitory effect on eating in rats. Science 206 (1979) 850-852
41. Fruin A.B., Arnelo U., Granqvist L., Strommer L., Larsson J., and Permert J. Weight loss induced by islet amyloid polypeptide (IAPP) is not fully explained by reduction in food intake. Digestion 58 (1997) 55
42. Gebre-Medhin S., Mulder H., Ahren B., Pekny M., Tornell J., Sundler F., Westermark P., and Betsholtz C. Mice lacking IAPP develop and reproduce normally and appear metabolically unaffected. Diabetologia 39 (1996) A181
43. Gebre-Medhin S., Mulder H., Pekny M., Zhang Y., Tornell J., Westermark P., Sundler F., Ahren B., and Betsholtz C. Altered glucose homeostasis, body weight and nociception in IAPP (amylin) null mutant mice. Diabetes 40 (1997) 29A
44. Gebre-Medhin S., Mulder H., Pekny M., Zhang Y.Z., Tornell J., Westermark P., Sundler F., Ahren B., and Betsholtz C. IAPP (amylin) null mutant mice; plasma levels of insulin and glucose, body weight and pain responses. Diabetologia 40 (1997) A26
45. Gedulin B., Smith P., Gedulin G., Baron A., and Young A. Amylin potently inhibits ghrelin secretion in rats. Diabetes 53 suppl. 2 (2004) A340
46. Granqvist L., Permert J., Arnelo U., Adrian T., Westermark P., Smith D., and Reidelberger R. Effects of AC187, IAPP (8-37). and CGRP (8-37). on IAPP induced anorexia in rats. Digestion 58 (1997) 55
47. Grill H.J., and Kaplan J.M. The neuroanatomical axis for control of energy balance. Front. Neuroendocrinol. 23 (2002) 2-40
48. Horn C.C., Addis A., and Friedman M.I. Neural substrate for an integrated metabolic control of feeding behavior. Am. J. Physiol. 45 (1999) R113-R119
49. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
50. Lutz T.A., Del Prete E., and Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol. Behav. 55 (1994) 891-895
51. Lutz T.A., Del Prete E., and Scharrer E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16 (1995) 457-462
52. Lutz T.A., Geary N., Szabady M.M., DelPrete E., and Scharrer E. Amylin decreases meal size in rats. Physiol. Behav. 58 (1995) 1197-1202
53. Lutz T.A., Del Prete E., Szabady M.M., and Scharrer E. Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP (8-37). Peptides 17 (1996) 119-124
54. Lutz T.A., Del Prete E., Walzer B., and Scharrer E. The histaminergic, but not the serotoninergic, system mediates amylin's anorectic effect. Peptides 17 (1996) 1317-1322
55. Lutz T.A., Pieber T.R., Walzer B., Del Prete E., and Scharrer E. Different influence of CGRP (8-37), an amylin and CGRP antagonist, on the anorectic effects of cholecystokinin and bombesin in diabetic and normal rats. Peptides 18 (1997) 643-649
56. Lutz T.A., Rossi R., Althaus J., Del Prete E., and Scharrer E. Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats. Neurosci. Lett. 230 (1997) 159-162
57. Lutz T.A., Althaus J., Rossi R., and Scharrer E. Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers. Am. J. Physiol. 274 (1998) R1777-R1782
58. Lutz T.A., Rossi R., Althaus J., Del Prete E., and Scharrer E. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides 19 (1998) 1533-1540
59. Lutz T.A., Senn M., Althaus J., Del Prete E., Ehrensperger F., and Scharrer E. Lesion of the area postrema nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 19 (1998) 309-317
60. Lutz T.A., Tschudy S., Rushing P.A., and Scharrer E. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT). Peptides 21 (2000) 233-238
61. Lutz T.A., Tschudy S., Rushing P.A., and Scharrer E. Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC253. Physiol. Behav. 70 (2000) 533-536
62. Lutz T.A., Mollet A., Rushing P.A., Riediger T., and Scharrer E. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1005-1011
63. Lutz T.A., Rushing P.A., and Riediger T. Repeated salmon calcitonin injection lowers body weight and body fat. Sci. World J. 1 (2001) 25
64. Lutz T.A., Tschudy S., Mollet A., Geary N., and Scharrer E. Dopamine D (2). receptors mediate amylin's acute satiety effect. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1697-R1703
65. Lutz T.A., Edwards G.L., Grabler V., Becskei C., and Riediger T. Amylin's anorectic effect depends on an intact lateral parabrachial nucleus (IPBN). Appetite 40 (2003) 346-347
66. Macintosh C., Morley J.E., and Chapman I.M. The anorexia of aging. Nutrition 16 (2000) 983-995
67. Mack C., Hoyt J., Moore C., Jodka C., and Sams-Dodd F. Sustained reduction in food intake and body weight in high fat-fed rats during 28-day amylin infusion. Diabetes 52 suppl. 1 (2003) A389
68. Marrero D., Kruger D., Burrell T., Gloster M., Crean J., Herrmann K., and Kolterman O. Patients with type 1 diabetes: Perceptions associated with pramlintide as an adjunctive treatment to insulin. Diabetes 53 suppl. 2 (2004) A137-A138
69. Miller C.C., Dilts R.P., Young A.A., and Edwards G.L. Lesion of the area postrema (AP) attenuates hindbrain cFOS expression after amylin treatment. Proc. Neurosci. Abstr. 24 (1998) 847.10
70. Mollet A., Lutz T.A., Meier S., Riediger T., Rushing P.A., and Scharrer E. Histamine H (1). receptors mediate the anorectic action of the pancreatic hormone amylin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R1442-R1448
71. Mollet A., Meier S., Grabler V., Gilg S., Scharrer E., and Lutz T.A. Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin. Peptides 24 (2003) 91-98
72. Mollet A., Meier S., Riediger T., and Lutz T.A. Histamine H (1). receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin. Peptides 24 (2003) 155-158
73. Mollet A., Gilg S., Riediger T., and Lutz T.A. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol. Behav. 81 (2004) 149-155
74. Morley J.E., and Flood J.F. Amylin decreases food intake in mice. Peptides 12 (1991) 865-869
75. Morley J.E., and Flood J.F. Effects of amylin and CGRP on appetite regulation and memory. Can. J. Physiol. Pharmacol. 72 (1994) 32
76. Morley J.E., Flood J., and Silver A.J. Effects of peripheral hormones on memory and ingestive behaviors. Psychoneuroendocrinology 17 (1992) 391-399
77. Morley J.E., Morley P.M., and Flood J.F. Anorectic effects of amylin in rats over the life span. Pharmacol. Biochem. Behav. 44 (1993) 577-580
78. Morley J.E., Flood J.F., Horowitz M., Morley P.M.K., and Walter M.J. Modulation of food intake by peripherally administered amylin. Am. J. Physiol. 267 (1994) R178-R184
79. Morley J.E., Flood J.F., Farr S.A., Perry H.J., Kaiser F.E., and Morley P.M.K. Effects of amylin on appetite regulation and memory. Can. J. Physiol. Pharmacol. 73 (1995) 1042-1046
80. Morley J.E., Farr S.A., and Flood J.F. Peripherally administered calcitonin gene-related peptide decreases food intake in mice. Peptides 17 (1996) 511-516
81. Morley J.E., Suarez M.D., Mattamal M., and Flood J.F. Amylin and food intake in mice: Effects on motivation to eat and mechanism of action. Pharmacol. Biochem. Behav. 56 (1997) 123-129
82. Phifer C.B., and Berthoud H.R. Duodenal nutrient infusions differentially affect sham feeding and Fos expression in rat brain stem. Am. J. Physiol. 274 (1998) R1725-R1733
83. Pieber T.R., Roitelman J., Lee Y., Luskey K.L., and Stein D.T. Direct plasma radioimmunoassay for rat amylin-(1-37): Concentrations with acquired and genetic obesity. Am. J. Physiol. 267 (1994) E156-E164
84. Rauch M., Schmid H.A., Koch J., Riediger T., and Simon E. Blood-borne amylin stimulates water intake via central action on neurons of the subfornical organ. Pflugers Arch. 433 (1997) 618
85. Reidelberger R.D., Arnelo U., Granqvist L., and Permert J. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R605-R611
86. Reidelberger R.D., Kelsey L., and Heimann D. Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R1395-R1404
87. Reidelberger R.D., Haver A.C., Arnelo U., Smith D.D., Schaffert C.S., and Permert J. Amylin receptor blockade stimulates food intake in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R568-R574
88. Riediger T., Rauch M., and Schmid H.A. Actions of amylin on subfornical organ neurons and on drinking behavior in rats. Am. J. Physiol. 276 (1999) R514-R521
89. Riediger T., Schmid H.A., Young A.A., and Simon E. Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones. Brain Res. 837 (1999) 161-168
90. Riediger T., Schmid H.A., Lutz T.A., and Simon E. Amylin and glucose co-activate area postrema neurons of the rat. Neurosci. Lett. 328 (2002) 121-124
91. Riediger T., Zuend D., Becskei C., and Lutz T.A. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R114-R122
92. Roth J.D., and Anderson C. Amylin induces weight loss and decreases body fat through both anorexigenic and metabolic effects, edn. (2004), Keystone Symposia
93. Roth J., Hughes H., and Anderson C. Amylin-induced changes in body weight and body composition in high-fat fed female rats: Effects of prior or concurrent food restriction. Obes. Res. 12 Suppl. (2004) A109-A110
94. Rowland N.E., Crews E.C., and Gentry R.M. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul. Pept. 71 (1997) 171-174
95. Rowland N.E., and Richmond R.M. Area postrema and the anorectic actions of dexfenfluramine and amylin. Brain Res. 820 (1999) 86-91
96. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., and Woods S.C. Amylin: A novel action in the brain to reduce body weight. Endocrinology 141 (2000) 850-853
97. Rushing P.A., Lutz T.A., Seeley R.J., and Woods S.C. Amylin and insulin interact to reduce food intake in rats. Horm. Metab. Res. 32 (2000) 62-65
98. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., D'Alessio D.A., Air E.L., and Woods S.C. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142 (2001) 5035-5038
99. Rushing P.A., Seeley R.J., Air E.L., Lutz T.A., and Woods S.C. Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences. Peptides 23 (2002) 985-988
100. Simon E. Interface properties of circumventricular organs in salt and fluid balance. News Physiol. Sci. 15 (2000) 61-67
101. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
102. Watkins J., Bhavsar S., and Young A.A. Effect of amylin to inhibit food intake in rats can be blocked with the selective amylin receptor antagonist, AC187. Program and Abstracts, 10th International Congress of Endocrinology (1996) 419
103. Watkins J., Bhavsar S., and Young A. Amylin's effect on reduction of food intake in rats may be centrally mediated. International Behavioral Neuroscience Society, Apr. 24-27, San Diego, CA. 1997 (1997)
104. Weyer C., Maggs D.G., Fineman M., Gottlieb A.D., Shen L.Z., and Kolterman O.G. Amylin replacement with pramlintide as an adjunct to insulin therapy facilitates a combined improvement in glycemic and weight control in type 1 diabetes. Diabetologia 44 suppl. 1 (2001) A237
105. Weyer C., Chapman I., Parker B., Doran S., Feinle-Bisset C., Wishart J., Wang Y., Burns C., Lush C., and Horowitz M. Effect of pramlintide on ad-libitum food intake in obese subjects and subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled, crossover study. Obes. Res. 12 suppl. (2004) A28
106. Wolfe A., Massi M., and Geary N. Exogenous amylin inhibits ethanol intake in Sardinian alcohol-preferring rats. Appetite 40 (2003) 370
107. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., and Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
108. Yamamoto T., and Sawa K. c-Fos-like immunoreactivity in the brainstem following gastric loads of various chemical solutions in rats. Brain Res. 866 (2000) 135-143
109. Yamamoto T., and Sawa K. Comparison of c-fos-like immunoreactivity in the brainstem following intraoral and intragastric infusions of chemical solutions in rats. Brain Res. 866 (2000) 144-151
110. Yamamoto Y., Nakamuta H., Koida M., Seyler J.K., and Orlowski R.C. Calcitonin-induced anorexia in rats: A structure-activity study by intraventricular injections. Jpn. J. Pharmacol. 32 (1982) 1013-1017
111. Young A. Role of amylin in nutrient intake: Animal studies. Diabet. Med. 14 (1997) S14-S18
112. Young A.A., and Bhavsar S. Genetically obese (ob/ob). Mice are more sensitive to amylin and endotoxin-induced suppression of food intake. Program and Abstracts, 10th International Congress of Endocrinology (1996) 419
113. Young A.A., Vine W., Gedulin B.R., Pittner R., Janes S., Gaeta L.S.L., Percy A., Moore C.X., Koda J.E., Rink T.J., and Beaumont K. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Dev. Res. 37 (1996) 231-248
114. Young A.A., Smith P., Gedulin G., Baron A., and Gedulin B.R. Amylin inhibition of ghrelin secretion depends upon an intact area postrema. Diabetologia 47 suppl. 1 (2004) A237